Eckert & Ziegler Increases Dividend

Insider information pursuant to Article 17 MAR

Berlin, 20 March 2018. Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist for isotope-based applications in medicine, science and industry achieved sales of approx. 144.8 million EUR in the fiscal year 2017. As the Supervisory Board stated at its balance sheet meeting, the net profit was 14.7 million EUR or 2.78 EUR per share. The expectations for the fiscal year 2017 were met.

Without discontinued operations sales achieved 138.6 million EUR, net profit 11.6 million EUR and earnings per share 2.19 EUR.

At the General Shareholders’ Meeting to be held on 30 May 2018, the Executive Board and the Supervisory Board will propose a dividend of  0.80 EUR per share entitled to a dividend (previous year: 0.66 EUR per share).

The income statement, balance sheet and cash flow statement for the past fiscal year can be found on March 22, 2018 here.
The audited annual financial statements will be posted there on March 29, 2018.

For enquiries please contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@dont-want-spam.ezag.de, www.ezag.com